Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

This review aims to provide a translational perspective on recent developments in heart
failure with preserved ejection fraction (HFpEF), linking mechanistic insights to potential …

Bioelectronic systems typically rely on radiofrequency wireless components to interface with
the human body, but such components are bulky and energy-demanding, which limits the …

There is an unmet need for effective treatment strategies to reduce morbidity and mortality in
patients with heart failure with preserved ejection fraction (HFpEF). Until recently, attention in …

In response to the COVID-19 pandemic, US federal and state governments have
implemented wide-ranging stay-at-home recommendations as a means to reduce spread of …

Background: Despite increased use of guideline-directed medical therapy (GDMT), some
patients with heart failure and reduced ejection fraction (HFrEF) remain at high risk for …

Despite increasing prevalence in critical care units, cardiogenic shock related to HF (HF-CS)
is incompletely understood and distinct from acute myocardial infarction related CS. This …

Although it is a rare disease, the number of available therapeutic options for treating
pulmonary arterial hypertension has increased since the late 1990s, with multiple drugs …

ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Early telemonitoring of weights and symptoms did not decrease heart failure hospitalizations
but helped identify steps toward effective monitoring programs. A signal that is accurate and …